The third scenario, in which the booster dose was with the Pfizer vaccine, showed the highest percentages of effectiveness: 56.8% against symptomatic infections and 85.5% against severe cases.

(JTA) — Israel has begun inviting immunocompromised adults to receive a third dose of the COVID-19 vaccine, as case rates in the country have risen again due to the spread of the Delta variant.

Valneva and Pfizer's shot, called VLA15 ... "We are encouraged by [this] data, which support[s] the potential benefit of booster doses across all examined age groups," commented Juan Carlos ...

Pfizer and BioNTech have formally asked for FDA approval of a third dose of their COVID-19 vaccine BNT162b2 in people aged over 16, as the US prepares to get its booster campaign underway.

With the country entering a “postpandemic phase,” the Commission on Audit (COA) has warned that P152 million worth of ultra-low-temperature freezers procured by the ...

Pfizer Inc. (NYSE:PFE), one of the world's largest pharmaceutical companies with a market capitalization of $151.25 billion, finds itself at a critical juncture as it navigates the post-pandemic ...

Pfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...

Vaccination bills are popping up in more than 15 states as lawmakers aim to potentially resurrect or create new religious ...

Fla., praised news that President Donald Trump will reinstate service members expelled for refusing to take the COVID-19 ...

Hospitalizations and general "syndromic" cases were at 10+ statewide for the week. The number of reported COVID cases ...

Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Scrap for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has reported a Standalone Total ...